Desulfovibrio vulgaris interacts with novel gut epithelial immune receptor LRRC19 and exacerbates colitis

Runxiang Xie,Yu Gu,Mengfan Li,Lingfeng Li,Yunwei Yang,Yue Sun,Bingqian Zhou,Tianyu Liu,Sinan Wang,Wentian Liu,Rongcun Yang,Xiaomin Su,Weilong Zhong,Bangmao Wang,Hailong Cao

DOI: https://doi.org/10.1186/s40168-023-01722-8

IF: 15.5

2024-01-05

Microbiome

Abstract:The overgrowth of Desulfovibrio , an inflammation promoting flagellated bacteria, has been found in ulcerative colitis (UC) patients. However, the molecular mechanism in promoting colitis remains unestablished.

microbiology

What problem does this paper attempt to address?

This paper aims to explore the mechanism of action of sulfate-reducing bacteria *Desulfovibrio vulgaris* (abbreviated as *D. vulgaris*) and its flagellin protein (DVF) in ulcerative colitis (UC). The study found that *D. vulgaris* significantly increased in the fecal samples of UC patients and was associated with the severity of the disease. Further mouse experiments confirmed that *D. vulgaris* and its flagellin protein DVF could exacerbate colitis symptoms, primarily through interaction with the intestinal epithelial immune receptor LRRC19, inducing the production of pro-inflammatory cytokines, thereby promoting the inflammatory response. Additionally, the researchers screened a small molecule compound, typhaneoside, which can block the interaction between DVF and LRRC19, and validated its effective therapeutic effect on colitis in a mouse model. Therefore, targeting the DVF-LRRC19 interaction may become a new strategy for treating ulcerative colitis.